- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩89,100.00
7D
0.7%
1Y
-1.2%
Oscotec
Market Cap: ₩1.6t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩39,650.00
7D
-2.3%
1Y
45.5%
JW Shinyak
Market Cap: ₩130.5b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,065.00
7D
58.7%
1Y
28.3%
DongKoo Bio & Pharma
Market Cap: ₩113.4b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩4,125.00
7D
2.6%
1Y
-25.0%